Anika Therapeutics (ANIK)
(Delayed Data from NSDQ)
$16.53 USD
-0.58 (-3.39%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $16.54 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 3/12/25 |
---|---|
Current Quarter | 0.44 |
EPS Last Quarter | -0.25 |
Last EPS Surprise | -183.33% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 1.00 |
Next Year | 1.32 |
EPS (TTM) | -4.69 |
P/E (F1) | 16.53 |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 45.44M | 42.47M | 170.05M | 179.42M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 45.44M | 42.47M | 170.05M | 179.42M |
Low Estimate | 45.44M | 42.47M | 170.05M | 179.42M |
Year ago Sales | 42.97M | 40.52M | 166.66M | 170.05M |
Year over Year Growth Est. | 5.75% | 4.81% | 2.03% | 5.51% |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.44 | 0.29 | 1.00 | 1.32 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.44 | 0.29 | 1.00 | 1.32 |
Low Estimate | 0.44 | 0.29 | 1.00 | 1.32 |
Year ago EPS | -4.30 | -0.31 | -5.64 | 1.00 |
Year over Year Growth Est. | 110.23% | 193.55% | 117.73% | 32.00% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.44 | 0.29 | 1.00 | 1.32 |
7 Days Ago | 0.44 | 0.29 | 1.00 | 1.32 |
30 Days Ago | 0.44 | 0.29 | 1.00 | 1.32 |
60 Days Ago | 0.44 | 0.29 | 0.66 | 0.92 |
90 Days Ago | 0.43 | 0.22 | 0.70 | 0.92 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.44 | 0.29 | 1.00 | 1.32 |
Zacks Consensus Estimate | 0.44 | 0.29 | 1.00 | 1.32 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.25 | 0.17 | -0.31 | -4.30 | NA |
Estimate | 0.30 | 0.23 | -0.19 | -0.26 | NA |
Difference | -0.55 | -0.06 | -0.12 | -4.04 | -1.19 |
Surprise | -183.33% | -26.09% | -63.16% | -1,553.85% | -456.61% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more